2016. ISPOR Annual International Meeting – The Role of Clinical Outcome Assessment (COA) Data in the Drug Approval Process of Products for the Treatment of Duchenne Muscular Dystrophy in the USA and Europe: A Review of Guidance Documents and Authorizations of Medicinal Products

Perret C, Perrier LL, Acquadro C. The Role of Clinical Outcome Assessment (COA) Data in the Drug Approval Process of Products for the Treatment of Duchenne Muscular Dystrophy in the USA and Europe: A Review of Guidance Documents and Authorizations of Medicinal Products. Value Health. 2016 May;19(3):A253-254. Presented at: ISPOR 21st Annual International Meeting; May 24 2016; Washington DC, USA.